Clinical significance of cyclophosphamide-induced cardiotoxicity.
Taniguchi
Ikuo
I
D016026:Bone Marrow Transplantation; D003520:Cyclophosphamide / Q000008:administration & dosage / Q000009:adverse effects*; D004305:Dose-Response Relationship, Drug; D004452:Echocardiography; D006084:Graft Rejection / Q000517:prevention & control; D006321:Heart / Q000187:drug effects; D006470:Hemorrhage / Q000139:chemically induced / Q000175:diagnosis / Q000401:mortality; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage / Q000009:adverse effects*; D008279:Magnetic Resonance Imaging; D009205:Myocarditis / Q000139:chemically induced* / Q000175:diagnosis / Q000401:mortality; D009206:Myocardium / Q000473:pathology; D012720:Severity of Illness Index
D007166:Immunosuppressive Agents; D003520:Cyclophosphamide